Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis

• المؤلفون الرئيسيون: Daniel Sur (مؤلف), Cristina Lungulescu (مؤلف), Ștefan Spînu (مؤلف), Alecsandra Gorzo (مؤلف), Elena-Adriana Dumitrescu (مؤلف), Dan Ionut Gheonea (مؤلف), Cristian-Virgil Lungulescu (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: In the phase III RECOURSE trial, the orally administered combination trifluridine/tipiracil (FTD/TPI) demonstrated a survival benefit and an acceptable safety profile, earning approval as a third-line therapy in metastatic colorectal cancer (mCRC). This study aimed to assess the efficacy...